Skip to main content

Dr. Ryan Ungaro

Gastroenterology (Gastroenterology Physician)

  • Medicare participating

At a glance

Years since graduation
17
In the NPI registry since
2009
Medicare patients seen, 2024
61

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2009Medical school: Icahn School of Medicine at Mount Sinai
  • 2009Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Gastroenterology Physician primary
    NY license 260703

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Gastroenterology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
61
Services billed
101
Patients’ average age
71
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes2415

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Mesalamine
Other prescribers in New York, NY
34
Stelara (ustekinumab)31
Xeljanz (tofacitinib citrate)14
Remicade (infliximab)11

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 6 companies reported 34 payments worth $45,014 in total to this clinician.

By company
AbbVie Inc.$25,935
Janssen Global Services, LLC$8,699
Pfizer Inc.$6,436
Genentech USA, Inc.$3,711
Janssen Biotech, Inc.$211
Lilly USA, LLC$21.10
By type
Consulting Fee$29,234
Travel and Lodging$9,202
Compensation for services other than consulting (speaking, faculty)$5,558
Food and Beverage$1,020

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jun 24, 2025AbbVie Inc.
Jun 24, 2025
Consulting Fee$13,475
Jun 5, 2025AbbVie Inc.
Jun 5, 2025
Travel and Lodging
travel to HOOFDDORP, Netherlands · in-kind
$7,383
Feb 1, 2025Janssen Global Services, LLC
Feb 1, 2025
Consulting Fee
TREMFYA · Immunology
$7,098
Apr 1, 2025Pfizer Inc.
Apr 1, 2025
Compensation for services other than consulting (speaking, faculty)
VELSIPITY · INFLAMMATION;PAIN
$5,558
Dec 18, 2025AbbVie Inc.
Dec 18, 2025
Consulting Fee
SKYRIZI · IMMUNOLOGY
$3,675
Feb 5, 2025Genentech USA, Inc.
Feb 5, 2025
Consulting Fee$3,525
Dec 1, 2025Janssen Global Services, LLC
Dec 1, 2025
Consulting Fee
TREMFYA · Immunology
$1,461
Mar 21, 2025Pfizer Inc.
Mar 21, 2025
Travel and Lodging
VELSIPITY · INFLAMMATION;PAIN · travel to New York, NY · in-kind
$835
Jun 2, 2025AbbVie Inc.
Jun 2, 2025
Travel and Lodging
travel to HOOFDDORP, Netherlands · in-kind
$203
Jun 3, 2025AbbVie Inc.
Jun 3, 2025
Travel and Lodging
travel to HOOFDDORP, Netherlands · in-kind
$203
All 13 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 18, 2025AbbVie Inc.
Dec 18, 2025
Consulting Fee
SKYRIZI · IMMUNOLOGY
$3,675
Dec 1, 2025Janssen Global Services, LLC
Dec 1, 2025
Consulting Fee
TREMFYA · Immunology
$1,461
Jun 24, 2025AbbVie Inc.
Jun 24, 2025
Consulting Fee$13,475
Jun 5, 2025AbbVie Inc.
Jun 5, 2025
Travel and Lodging
travel to HOOFDDORP, Netherlands · in-kind
$7,383
Jun 5, 2025AbbVie Inc.
Jun 5, 2025
Travel and Lodging
travel to HOOFDDORP, Netherlands · in-kind
$179
Jun 4, 2025AbbVie Inc.
Jun 4, 2025
Travel and Lodging
travel to HOOFDDORP, Netherlands · in-kind
$203
Jun 3, 2025AbbVie Inc.
Jun 3, 2025
Travel and Lodging
travel to HOOFDDORP, Netherlands · in-kind
$203
Jun 2, 2025AbbVie Inc.
Jun 2, 2025
Travel and Lodging
travel to HOOFDDORP, Netherlands · in-kind
$203
Jun 2, 2025AbbVie Inc.
Jun 2, 2025
Travel and Lodging
travel to HOOFDDORP, Netherlands · in-kind
$197
Apr 1, 2025Pfizer Inc.
Apr 1, 2025
Compensation for services other than consulting (speaking, faculty)
VELSIPITY · INFLAMMATION;PAIN
$5,558
Mar 21, 2025Pfizer Inc.
Mar 21, 2025
Travel and Lodging
VELSIPITY · INFLAMMATION;PAIN · travel to New York, NY · in-kind
$835
Feb 5, 2025Genentech USA, Inc.
Feb 5, 2025
Consulting Fee$3,525
Feb 1, 2025Janssen Global Services, LLC
Feb 1, 2025
Consulting Fee
TREMFYA · Immunology
$7,098

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in New York →

Industry-funded research

Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $66,421 in research payments for these studies, mostly to the institutions running them.

  • A Randomized, Double-blind, Placebo-Controlled Phase 3b Study to Evaluate the Short- and Long-term Efficacy and Safety of Dual Targeted Therapy With Intravenous Vedolizumab and Oral Upadacitinib Compared With Intrav…
    Takeda Pharmaceuticals U.S.A., Inc.
  • A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1)
    Genentech, Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Gastroenterology clinicians in New York

Sources

NPI registry (CMS NPPES, November 2026; record last updated February 22, 2019), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1790927150. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.